Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith Rademacher

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Expert Opinion on Emerging Drugs|February 25, 2018
Emerging drugs for the treatment of axial spondyloarthritisJudith Rademacher, Denis Poddubnyy
Die Ophthalmologie|January 12, 2023
[HLA-B27 positive anterior uveitis : Clinical aspects, diagnostics, interdisciplinary management and treatment]Peter Werkl, Judith Rademacher, Uwe Pleyer
Klinische Monatsblatter Fur Augenheilkunde|April 18, 2020
[Anterior Uveitis: Clinic, Diagnostic Procedure and Treatment Options]Uwe Pleyer, Dominika Pohlmann, Judith Rademacher
Therapeutic Advances in Musculoskeletal Disease|September 23, 2020
Uveitis in spondyloarthritisJudith Rademacher, Denis Poddubnyy, Uwe Pleyer
Die Ophthalmologie|December 12, 2023
HLA-B27-positive anterior uveitis : Clinical aspects, diagnostics, interdisciplinary management, and treatmentPeter Werkl, Judith Rademacher, Uwe Pleyer
Zeitschrift Fur Rheumatologie|December 2, 2024
[Microbial and genetic factors in the pathogenesis of spondyloarthritis]Judith Rademacher, Denis Poddubnyy, Valeria Rios Rodriguez
Expert Opinion on Emerging Drugs|September 10, 2019
Emerging drugs for the treatment of noninfectious uveitisUwe Pleyer, Dominika Pohlmann, Esra Kardeş, et al.
Methods in Cell Biology|May 5, 2024
Harmonized analysis of PBMC by mass cytometryAxel R Schulz, Judith Rademacher, Vera Bockhorn, et al.
Rheumatology (Oxford, England)|September 29, 2017
Chronic meningococcaemia-a medical oxymoronJudith Rademacher, Hildrun Haibel, Denis Poddubnyy, et al.
Seminars in Immunopathology|August 22, 2015
Functional autoantibodies in systemic sclerosisJeannine Günther, Judith Rademacher, Jakob M van Laar, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Expert Opinion on Emerging Drugs|February 25, 2018
Emerging drugs for the treatment of axial spondyloarthritisJudith Rademacher, Denis Poddubnyy
Die Ophthalmologie|January 12, 2023
[HLA-B27 positive anterior uveitis : Clinical aspects, diagnostics, interdisciplinary management and treatment]Peter Werkl, Judith Rademacher, Uwe Pleyer
Klinische Monatsblatter Fur Augenheilkunde|April 18, 2020
[Anterior Uveitis: Clinic, Diagnostic Procedure and Treatment Options]Uwe Pleyer, Dominika Pohlmann, Judith Rademacher
Therapeutic Advances in Musculoskeletal Disease|September 23, 2020
Uveitis in spondyloarthritisJudith Rademacher, Denis Poddubnyy, Uwe Pleyer
Die Ophthalmologie|December 12, 2023
HLA-B27-positive anterior uveitis : Clinical aspects, diagnostics, interdisciplinary management, and treatmentPeter Werkl, Judith Rademacher, Uwe Pleyer
Zeitschrift Fur Rheumatologie|December 2, 2024
[Microbial and genetic factors in the pathogenesis of spondyloarthritis]Judith Rademacher, Denis Poddubnyy, Valeria Rios Rodriguez
Expert Opinion on Emerging Drugs|September 10, 2019
Emerging drugs for the treatment of noninfectious uveitisUwe Pleyer, Dominika Pohlmann, Esra Kardeş, et al.
Methods in Cell Biology|May 5, 2024
Harmonized analysis of PBMC by mass cytometryAxel R Schulz, Judith Rademacher, Vera Bockhorn, et al.
Rheumatology (Oxford, England)|September 29, 2017
Chronic meningococcaemia-a medical oxymoronJudith Rademacher, Hildrun Haibel, Denis Poddubnyy, et al.
Seminars in Immunopathology|August 22, 2015
Functional autoantibodies in systemic sclerosisJeannine Günther, Judith Rademacher, Jakob M van Laar, et al.
Pageof 6